Effect of nizatidine on olanzapine-associated weight gain in schizophrenic patients in Korea: A pilot study

Human Psychopharmacology

Volumn 18, Issue 6, 2003, Pages 453-456

  Pae, Chi Un ^a   Kim, Jung Jin ^a   Lee, Kyung Uk ^a   Lee, Chang Uk ^a   Bahk, Won Myong ^a   Lee, Soo Jung ^a   Lee, Chul ^a   Paik, In Ho ^a  

^a The Catholic University of Korea College of Medicine   (South Korea)

Author keywords

Nizatidine; Olanzapine; Schizophrenia; Schizophreniform disorder; Weight gain

Indexed keywords

ALPRAZOLAM; AMANTADINE; ANXIOLYTIC AGENT; BENZATROPINE; CIMETIDINE; HISTAMINE H2 RECEPTOR ANTAGONIST; LORAZEPAM; NIZATIDINE; OLANZAPINE; TETRAHYDROLIPSTATIN;

ADULT; ARTICLE; BODY MASS; BODY WEIGHT; BODY WEIGHT DISORDER; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE DURATION; FEMALE; HUMAN; KOREA; MALE; PILOT STUDY; PRIORITY JOURNAL; PSYCHOMETRY; RATING SCALE; SCHIZOPHRENIA; SCHIZOPHRENIFORM DISORDER; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; WEIGHT GAIN;

ADULT; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; FEMALE; HISTAMINE H2 ANTAGONISTS; HUMANS; MALE; NIZATIDINE; OBESITY; PILOT PROJECTS; PIRENZEPINE; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMETRICS; SCHIZOPHRENIA; WEIGHT GAIN;

EID: 0042425851     PISSN: 08856222     EISSN: None     Source Type: Journal    
DOI: 10.1002/hup.507     Document Type: Article

References (14)

1. Allison DB, Mentore JL, Heo M, et al. 1999. Antipsychotic-induced weight gain: a comprehensive research synthesis. Am J Psychiatry 156: 1686-1696.
2. American Psychiatric Association. 1994. Diagnostic and Statistical Manual of Mental Disorder, 4th edn (DSM-IV). American Psychiatric Press: Washington, DC.
3. Atmaca M, Kuloglu M, Tezcan E, Ustundag B. Weight gain and serum leptin levels in patients on antipsychotic drugs, and nizatidine treatment. Hum Psychopharmacol (in press).
4. Basson BR, Kinon BJ, Taylor CC, Szymanski KA, Gilmore JA, Tollefson GD. 2001. Factors influencing acute weight change in patients with schizophrenia treated with olanzapine, haloperidol, or risperidone. J Clin Psychiatry 62: 231-238.
5. Breier A, Tanaka YR, Rochowdhury S, Clark S. 2001. Nizatidine for the prevention of olanzapine-associated weight gain in schizophrenia and related disorders. A randomized controlled double blind study [Abstract]. American Psychiatric Association Annual Meeting, 5-10 May 2001, New Orleans.
6. Furuta S, Kamada E, Suzuki T, et al. 2001. Inhibition of drug metabolism in human liver microsomes by nizatidine, cimetidine and omeprazole. Xenobiotica 31: 1-10.
7. Kaneko H, Mitsuma T, Uchida K, Nagai H, Harada M, Kotera H. 1995. Nizatidine accelerates gastric emptying of a solid meal in rats. Dig Dis Sci 40: 2043-2051.
8. Kay SR, Opler LA, Lindenmayer JP. 1988. Reliability and validity of the positive and negative syndrome scale for schizophrenics. Psychiatry Res 23: 99-110.
9. Kinon BJ, Basson BR, Gilmore JA, Tollefson GD. 2001. Long-term olanzapine treatment: weight change and weight-related health factors in schizophrenia. J Clin Psychiatry 62: 92-100.
10. Overall JE, Gorham DR. 1962. The brief psychiatric rating scale. Psychol Rep 10: 799-812.
11. Russell JM, Mackell JA. 2001. Bodyweight gain associated with atypical antipsychotics: epidemiology and therapeutic implications. CNS Drugs 15: 537-551.
12. 2 antagonist nizatidine may control olanzapine-associated weight gain in schizophrenic patients. Biol Psychiatry 48: 167-168.
13. Stoa-Birketvedt G, Paus PN, Ganss R, Ingebretsen OC, Florholmen J. 1998. Cimetidine reduces weight and improves metabolic control in overweight patients with type 2 diabetes. Int J Obes Relat Metab Disord 22: 1041-1045.
14. Werneke U, Taylor D, Sanders TA. 2002. Options for pharmacological management of obesity in patients treated with atypical antipsychotics. Int Clin Psychopharmacol 17: 145-160.